| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.43B | 7.17B | 6.26B | 5.03B | 1.23B | 395.40M |
| Gross Profit | 893.30M | 898.70M | 841.20M | 707.70M | -147.90M | -264.90M |
| EBITDA | 937.90M | 933.30M | 849.20M | 579.20M | -172.00M | -165.70M |
| Net Income | 454.10M | 446.80M | 399.20M | 290.80M | -315.40M | -271.20M |
Balance Sheet | ||||||
| Total Assets | 6.27B | 5.91B | 5.57B | 4.53B | 3.99B | 2.87B |
| Cash, Cash Equivalents and Short-Term Investments | 3.35B | 3.15B | 3.18B | 2.62B | 2.23B | 1.38B |
| Total Debt | 1.27B | 1.14B | 1.46B | 1.38B | 1.57B | 1.32B |
| Total Liabilities | 4.21B | 4.30B | 4.16B | 3.51B | 3.10B | 1.91B |
| Stockholders Equity | 2.06B | 1.61B | 1.41B | 1.01B | 896.60M | 964.20M |
Cash Flow | ||||||
| Free Cash Flow | 372.00M | 659.10M | 685.50M | 755.50M | 642.60M | -872.20M |
| Operating Cash Flow | 853.40M | 1.06B | 1.09B | 952.10M | 751.00M | -834.80M |
| Investing Cash Flow | -687.00M | -613.90M | -482.30M | -675.80M | -1.29B | 41.10M |
| Financing Cash Flow | -633.80M | -696.60M | -124.60M | -370.30M | 201.00M | 797.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.38B | 5.79 | 24.73% | 1.18% | 7.17% | -2.22% | |
73 Outperform | £4.14B | 9.73 | 15.14% | 1.21% | 10.51% | -9.26% | |
68 Neutral | £1.72B | 13.82 | 20.47% | 3.34% | 6.79% | -20.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | £3.99B | 18.87 | 6.73% | 3.80% | -0.06% | -13.45% | |
50 Neutral | £1.35B | -48.61 | -65.76% | 2.50% | 4.58% | -24.15% | |
44 Neutral | £657.70M | -4.11 | -90.46% | 4.48% | -30.52% | -2064.92% |